← CGNX
CGNX— COGNEX CORP
Health CareIndustrial Instruments For Measurement, Display, and Control
| Metric | FY2025 | FY2025 | FY2025 | FY2025 | FY2024 | FY2024 | FY2024 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $994.4M+8.7% | $914.5M+9.2% | $837.5M | — | — | — | — | — | — | — |
| Cost of revenue | $329.0M+13.9% | $288.7M+22.2% | $236.3M | — | — | — | — | — | — | — |
| Gross margin | $665.4M+6.3% | $625.8M+4.1% | $601.2M | — | — | — | — | — | — | — |
| Research, development, and engineering expenses | $139.0M-0.6% | $139.8M+0.3% | $139.4M | — | — | — | — | — | — | — |
| Selling, general, and administrative expenses | $363.9M-1.9% | $370.9M+9.4% | $339.1M | — | — | — | — | — | — | — |
| Loss (recovery) from fire | $0 | $0+100.0% | -$8.0M | — | — | — | — | — | — | — |
| Operating income | $162.6M+41.3% | $115.1M-12.0% | $130.7M | — | — | — | — | — | — | — |
| Foreign currency gain (loss) | -$4.1M-366.6% | $1.5M+115.3% | -$10.0M | — | — | — | — | — | — | — |
| Investment income | $16.9M+21.3% | $14.0M-0.9% | $14.1M | — | — | — | — | — | — | — |
| Other income (expense) | $7.4M+699.1% | $922K+55.7% | $592K | — | — | — | — | — | — | — |
| Income before income tax expense | $182.8M+39.0% | $131.5M-2.9% | $135.3M | — | — | — | — | — | — | — |
| Income tax expense on continuing operations | $68.4M+170.0% | $25.3M+14.5% | $22.1M | — | — | — | — | — | — | — |
| Net income | $114.4M+7.8% | $106.2M-6.2% | $113.2M | — | — | — | — | — | — | — |
| Net income (in dollars per share) | $680+9.7% | $620-4.6% | $650 | — | — | — | — | — | — | — |
| Basic (in shares) | $168.0M-2.0% | $171.4M-0.5% | $172.2M | — | — | — | — | — | — | — |
| Diluted (in shares) | $169.4M-1.9% | $172.6M-0.5% | $173.4M | — | — | — | — | — | — | — |
| Cash dividends per common share (in dollars per share) | $85+6.3% | $80+0.0% | $80+0.0% | $80-73.8% | $305+306.7% | $75+0.0% | $75+0.0% | $75-73.8% | $286+308.6% | $70 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.
